TY  - JOUR
AU  - Pol, Renato
AU  - Ruggiero, Tiziana
AU  - Giaccone, Luisa
AU  - Camisassa, Davide
AU  - Spadafora, Andrea
AU  - Rivetti, Giulia
AU  - Bezzi, Marta
AU  - Carossa, Stefano
PY  - 2019
DA  - 2019/10/21
TI  - Oral Management in Pre-HSCT Patients: An Evaluation of Oral and Systemic Complications
JO  - OBM Transplantation
SP  - 088
VL  - 03
IS  - 04
AB  - Objective
Hematopoietic stem cell transplant has to be preceded by chemotherapy and radiotherapy. The following neutropenia and thrombocytopenia could be the cause of post transplant complications. Patient undergoing transplantation need to be eradicated of any possible infectious focus. Nowadays there is not a uniformed protocol to manage these patients oral cavity.

Study  Design
The dental management was decided for each patient according to a more selective protocol, based on: type and size of lesions, symptomatology and time available. The sample was divided into three groups depending on which therapy was performed (selective protocol, radical protocol, no treatment). Patients were monitored after HSCT and all systemic complications occurred in the first 30, 100 days and 6 months were recorded.

Results
In four years 159 patients were visited, but only 139 underwent HSCT. There were no statistically significant differences among the three groups in the systemic complications after HSCT.

Conclusion
This work shows that there is no difference between a radical dental management and a more conservative one in the onset of infectious complications after HSCT; it also aims to provide a new approach for the oral management of these patients since the condition regimen is less myeloablative than in the past.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.1904088
DO  - 10.21926/obm.transplant.1904088
ID  - Pol2019
ER  -